As of 2026-09-12, the EV/EBITDA ratio of Intercept Pharmaceuticals Inc (ICPT) is -22.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ICPT's latest enterprise value is 915.51 mil USD. ICPT's TTM EBITDA according to its financial statements is -40.56 mil USD. Dividing these 2 quantities gives us the above ICPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.5x - 15.5x | 12.8x |
| Forward P/E multiples | 11.7x - 17.1x | 14.4x |
| Fair Price | (14.21) - (17.91) | (16.07) |
| Upside | -174.8% - -194.3% | -184.6% |
| Date | EV/EBITDA |